{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:54:03Z","timestamp":1775544843364,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.phrs.2023.106686","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T07:09:26Z","timestamp":1675494566000},"page":"106686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["IgD\/Fc\u03b4R is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein"],"prefix":"10.1016","volume":"189","author":[{"given":"Yujing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianling","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengshi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengxin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10230","key":"10.1016\/j.phrs.2023.106686_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.3","article-title":"Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia","volume":"7","author":"Richter-Pecha\u0144ska","year":"2017","journal-title":"Blood Cancer J."},{"issue":"1","key":"10.1016\/j.phrs.2023.106686_bib3","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA: A Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.phrs.2023.106686_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.6004\/jnccn.2019.0024","article-title":"Guidelines insights: acute lymphoblastic leukemia, version 1.2019","volume":"17","author":"Brown","year":"2019","journal-title":"J. Natl. Compr. Cancer Netw.: JNCCN"},{"issue":"12","key":"10.1016\/j.phrs.2023.106686_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123021","article-title":"Strategies to overcome resistance mechanisms in T-cell acute lymphoblastic leukemia","volume":"20","author":"Follini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2023.106686_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111621","article-title":"T-cell acute lymphoblastic leukemia-current concepts in molecular biology and management","volume":"9","author":"Shiraz","year":"2021","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.22416","article-title":"Pediatric T-cell acute lymphoblastic leukemia","volume":"56","author":"Karrman","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"issue":"37","key":"10.1016\/j.phrs.2023.106686_bib9","doi-asserted-by":"crossref","first-page":"58728","DOI":"10.18632\/oncotarget.11233","article-title":"Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia","volume":"7","author":"Yadav","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11864-020-00757-5","article-title":"Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults","volume":"21","author":"Patel","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11899-019-00501-3","article-title":"Relapsed T cell ALL: current approaches and new directions","volume":"14","author":"McMahon","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","article-title":"Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA","volume":"20","author":"Chen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/eji.201646547","article-title":"The enigmatic function of IgD: some answers at last","volume":"48","author":"Gutzeit","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.phrs.2023.106686_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114360","article-title":"The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis","volume":"183","author":"Wu","year":"2021","journal-title":"Biochem. Pharm."},{"issue":"11","key":"10.1016\/j.phrs.2023.106686_bib16","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.24245","article-title":"Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma","volume":"124","author":"Biggar","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2023.106686_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/16078454.2019.1642553","article-title":"Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma","volume":"24","author":"Dai","year":"2019","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.phrs.2023.106686_bib18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s12026-015-8777-3","article-title":"hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1\/S transition via IgD receptor activity","volume":"64","author":"Dai","year":"2016","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2023.106686_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147788","article-title":"The elevated secreted immunoglobulin D enhanced the activation of peripheral blood mononuclear cells in rheumatoid arthritis","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2023.106686_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fphar.2018.00004","article-title":"CP-25 attenuates the activation of CD4(+) T cells stimulated with immunoglobulin D in human","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2023.106686_bib21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fimmu.2020.00755","article-title":"Regulation of T cell activities in rheumatoid arthritis by the novel fusion protein IgD-Fc-Ig","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41401-021-00665-w","article-title":"An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis","volume":"43","author":"Hu","year":"2022","journal-title":"Acta Pharm. Sin."},{"issue":"8","key":"10.1016\/j.phrs.2023.106686_bib23","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2008-02-138073","article-title":"Activation of natural regulatory T cells by IgG Fc-derived peptide \"Tregitopes\"","volume":"112","author":"De Groot","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2023.106686_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clim.2009.01.009","article-title":"Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics","volume":"131","author":"De Groot","year":"2009","journal-title":"Clin. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106686_bib25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"De Groot","year":"2007","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2023.106686_bib26","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/aps.2017.105","article-title":"The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation","volume":"38","author":"Wu","year":"2017","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2023.106686_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105873","article-title":"hIgDFc-Ig inhibits B cell function by regulating the BCR-Syk-Btk-NF-\u03baB signalling pathway in mice with collagen-induced arthritis","volume":"173","author":"Zhang","year":"2021","journal-title":"Pharm. Res."},{"issue":"Pt A","key":"10.1016\/j.phrs.2023.106686_bib28","article-title":"IgD promotes pannus formation by activating Wnt5A-Fzd5-CTHRC1-NF-\u03baB signaling pathway in FLS of CIA rats and the regulation of IgD-Fc-Ig fusion protein","volume":"101","author":"Tai","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2023.106686_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109484","article-title":"IgD enhances the release of neutrophil extracellular traps (NETs) via Fc\u03b4R in rheumatoid arthritis patients","volume":"114","author":"Pan","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2023.106686_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbior.2018.09.012","article-title":"IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: an update","volume":"71","author":"Oliveira","year":"2019","journal-title":"Adv. Biol. Regul."},{"issue":"10","key":"10.1016\/j.phrs.2023.106686_bib31","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.phrs.2023.106686_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"3","key":"10.1016\/j.phrs.2023.106686_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.leukres.2011.11.010","article-title":"Rituximab for the treatment of adult relapsed\/refractory CD20 positive B-ALL patients: a pilot series","volume":"36","author":"Chevallier","year":"2012","journal-title":"Leuk. Res."},{"issue":"8","key":"10.1016\/j.phrs.2023.106686_bib34","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1509277","article-title":"Inotuzumab ozogamicin versus standard therapy for acute lymphoblastic leukemia","volume":"375","author":"Kantarjian","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.phrs.2023.106686_bib35","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/cncr.32116","article-title":"Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study","volume":"125","author":"Kantarjian","year":"2019","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2023.106686_bib36","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1634\/theoncologist.2016-0061","article-title":"Antidrug antibody formation in oncology: clinical relevance and challenges","volume":"21","author":"van Brummelen","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.phrs.2023.106686_bib37","doi-asserted-by":"crossref","first-page":"1298473","DOI":"10.1155\/2016\/1298473","article-title":"Immunogenicity of biotherapeutics: causes and association with posttranslational modifications","volume":"2016","author":"Kuriakose","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib38","doi-asserted-by":"crossref","first-page":"E1196","DOI":"10.1073\/pnas.1621258114","article-title":"IgD class switching is initiated by microbiota and limited to mucosa-associated lymphoid tissue in mice","volume":"114","author":"Choi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.phrs.2023.106686_bib39","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00018-020-03729-y","article-title":"Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways","volume":"78","author":"Wang","year":"2021","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.phrs.2023.106686_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102219","article-title":"A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity","volume":"49","author":"Xiao","year":"2022","journal-title":"Redox Biol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:32:12Z","timestamp":1733866332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"alternative-id":["S1043661823000427"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106686","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgD\/Fc\u03b4R is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106686"}}